Bibliografia

1. Consensus Development Conference: Diagnosis, Prophylaxis and Treatment of Osteoporosis. Am J Med 1993; 94: 646-50.

2. Melton LJ, Chrishillies EA, Cooper C, Lane AW, Riggs BL. Prospective: How many women have osteporosis? J Bone Miner Res 1992; 7: 1005-10.

3. Rossini M, Adami S. Farmacoeconomia e trattamento dell’osteoporosi. Farmacoeconomia 1999; 1: 5-11.

4. Canalis E. Regulation of bone remodeling. In: Favus MJ, Christakos S, Goldring SR et al (eds). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Third edition. Philadelphia: Lippincott-Raven Publishers, 1996; 29-34.

5. Recker RR. Bone biopsy and histomorphometry in clinical practice. In: Favus MJ, Christakos S, Goldring SR, et al. (eds) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Third edition. Philadelphia, Lippincott-Raven Publishers, 1996; 164-67.

6. Wagner HW, Fogelman I (eds). The evaluation of osteoporosis: dual energy X-ray absorptiometry in clinical practice. London: Martin Dunitz, 1996.

7. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal women. Technical report series 843. Geneva: WHO, 1994.

8. Black D, Cummings S, Genant H, Nevitt M, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older woman. J Bone Moner Res 1992(a); 7: 633-38.

9. Cummings SR, Nevitt MC, Browner WS, et al. For the Study of Osteoporotic Fractures Research Group (SOF). Risk factors for hip fractures in white women. N Engl J Med 1995; 332: 767-73.

10. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081-82.

11. Cummings SR. Treatable and untreatable risk factors for hip fractures. Bone 1996; 18(3): 165s-167s.

12. Cauley JA, Seeley DG, Ensurd K, Ettinger B, Black D, Cummings SR. For the study of Osteoporotic Fractures Research Group (SOF). Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995; 122: 9-16.

13. Lindsay R, MacLean A, Kraszewski A, Hart DM, Clark AC, Garwood J. Bone response to termination of oestrogen treatment. Lancet 1978; 1: 1325-27.

14. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopusal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. Multiple outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 2182: 637-45.

15. Stock JL, Avioli LV, et al. Calcitonin-salmon nasal spray reduces the incidence of new vertebral fractures in postmenopausal women: three-year interim results of the PROF study. J Bone Miner Res 1997; 12: S149.

16. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture intervention trial research group. Lancet 1996; 348: 1535-41.

17. Cummings SR, Black DM, Thompson DE, Applegate MD, Barret-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fractures intervention trial JAMA 1998; 280: 2077-82.

18. Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopusal osteoporosis. N Engl J Med 1990; 323: 73-79.

19. Felsenberg D, Alenfeld F, Bock O, et al. Placebo controled multicenter study of oral alendronate in postmenopausal osteoporotic women. FOSIT (Fosamax International Trial) Study Group. Maturitas 1998; 31: 35-44.

20. AA.VV. Randomised trial of the effects of risedronate on vertebral fractures in women with established osteporosis. Ost Int 2000; 11: 83-91.

21. AA.VV. The effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteporosis. JAMA 1999; 282(14): 1344-52.

22. Sinaki M. Exercise and physical therapy. Osteoporosis: etiology, diagnosis and management. Ed. by Lawrence Riggs and Joseph Melton III Raven Press, New York, 1988.

23. Birge SJ, Dalsky G. The role of exercise in preventing osteoporosis. Pubblc Health Rep 1989; 104: 54-58.

24. Shangold MM. Exercise in the menopausal women. Obstet Gynecol 1990; 75(4S): 53-58.

25. Cavanaugh DJ, Cann CE. Brisk walking does not stop bone loss in postmenopausal women. Bone 1988; 9(4): 201-4.

26. Goodman CE. Osteoporosis: Protective measures of nutrition and exercise. Geriatrics 1985; 40(4): 59-70.

27. Sinaki M, Mikkelsen BA. Postmenopusal spinal osteoporosis: flexion versus extension exercise. Arch Phis Med Rehabil 1984; 65: 593.

28. Sinaki M, McPhee MC, Hodgson SF, Merrit JM, Offord KP. Relationship between bone mineral density of spine and strenght of back extensor in healthy postmenopusal women. Mayo Clin Proc 1986; 61: 116-22.

29. Chow R, Harrison JE, Notarius C. Effect of two randomised exercise programmes on bone mass of healthy postmenopausal women. BMJ 1987; 295: 1441-44.

30. Arioli G, Pillosu W. Le sindromi algiche vertebrali: ergonomia e norme posturali. Ed. SKF, 1990.